Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease--modelling outcomes in active luminal and fistulizing disease in adults.
Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease - modeling outcomes in active luminal and fistulizing disease in adults